Rehydra+ Review (2026): A 6-Month Semaglutide Lock-In

Rehydra+ Wellness (rehydraplus.com) advertises semaglutide memberships at $119, $169 and $229 a month. Every one of them is six months long and explicitly non-cancelable — the phrase "Valid for 6 Months Non-Cancelable" appears on the membership page and again on each product page.¹ So the cheapest semaglutide membership is not $119. It is $714, committed on day one, with no exit.

We checked this in August 2026. It is the single most consequential term we found across seven telehealth sellers screened in the same pass, and it is worth understanding exactly, because the advertised figures are not wrong so much as incomplete in a way that changes the decision entirely.

The membership tiers, priced honestly

Rehydra+ sorts semaglutide into three dose tiers and prices each per month: $119 for 0.25 and 0.5 mg, $169 for 0.75 and 1.0 mg, $229 for 1.7 and 2.5 mg. Multiply by the six months you are committing to and the real numbers are $714, $1,014 and $1,374.¹ Tirzepatide runs the same structure at $1,014, $1,734 and $2,514.

There is no month-to-month membership rung. Not a more expensive one, not a hidden one — the option does not exist. Any comparison that shows "Rehydra+ from $119/month" alongside providers you can leave in thirty days is comparing two different products, and that is why our price-ordered semaglutide board does not carry a Rehydra+ membership figure.

Six months is also a long time to be certain about a drug you have not taken yet. Roughly the first two months of any semaglutide course are spent titrating through doses specifically to find out whether you tolerate it, and a meaningful share of people stop early because of nausea, reflux or fatigue — see semaglutide dosing and side effects. A contract you cannot cancel converts "this is not working for me" from a decision into a sunk cost. If you want the fuller version of that argument, it is in stopping semaglutide, which is about the clinical side of quitting; here the obstacle is contractual.

The one thing you can buy and walk away from

Rehydra+ also sells one-time supply packs, and those are cancel-anytime by definition — you buy a quantity of medication, and that is the transaction. Semaglutide four-week packs are priced by weekly dose: $149 at 0.25 mg, $179 at 0.5 mg, $199 at 1.0 mg, $269 at 1.7 mg and $289 at 2.5 mg, with eight- and twelve-week packs above those.¹

Two things to hold onto. First, "duration" here is supply length, not a billing cadence — a twelve-week pack is not a three-month subscription, it is a single purchase of twelve weeks of medication. Second, the price climbs steeply as you titrate: the same product at your likely maintenance dose costs roughly twice what it costs at your starting dose. The dose ladder is where that bites, and it is the reason a starting-dose headline is a poor guide to what a year costs.

If you are going to buy from Rehydra+ at all, the four-week pack is the only rung that does not require committing money you cannot get back.

What it will not tell you

No pharmacy is named. For a compounded product this is the disclosure that matters most, and Rehydra+ refers only to "our pharmacy partner". The stakes are set out in is compounded semaglutide still legal in 2026?.

The states are not named either. The About page says the company serves patients in 20 states. The 20 are never listed anywhere on the site. The state names that do appear are a checkout dropdown containing all 50, which is not a served-states list.

The certification claim could not be verified. Rehydra+ states in prose that it is certified, but the badge on the page is a self-hosted image file linking to a keyword search rather than to a certificate. There is no verifiable seal anywhere on the site. That is not the same as the claim being false — we are recording it as unverified, because unverified is what we observed.

Named clinicians are published — a medical director and two other prescribers — but no NPIs, so none can be checked against the national registry.

What else is in the cart

Rehydra+ runs as an ordinary e-commerce store, and the catalogue includes things that would not normally sit in a cart. Testosterone is sold as a standard product SKU. The peptide line includes oral BPC-157, oral KPV and oral tesamorelin — oral bioavailability for those peptides is not established, and selling them by that route is a catalogue signal in its own right.

None of that affects the semaglutide product directly. It does tell you what kind of operation you are buying from.

When your card is charged

At checkout, before a provider reviews your intake — it is a store, so you pay for the product first. The refund policy states there are no returns or refunds on prescription or compounded medication once shipped, and it does not clearly address what happens if you are declined. Financing is offered through a buy-now-pay-later provider, with a 2.99% processing fee on credit-card down payments disclosed only on the payment-plan page.

The regulatory screen

The trading name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index in August 2026, in a pass whose control query correctly returned a known February 2026 letter for an unrelated seller.² Clean on enforcement. The problems here are contractual and disclosure-related, not regulatory.

Where it lands

For most people looking for compounded semaglutide, this is the wrong shape of deal. A six-month non-cancelable contract asks you to guarantee half a year of payments on a medication whose tolerability you will not know for six weeks, from a seller that will not name its pharmacy or its states. Almost every alternative in this batch — The Edit at $209, Trellis Vitality at $150, Auren Rx at $199 with no commitment — lets you stop after a month.

If you have already taken semaglutide, know you tolerate it, know your maintenance dose and want a fixed quantity at a fixed price, the one-time four-week pack is a real product and a reasonable one. That is a narrow recommendation and it is meant to be. Compare it against everything else we track before you commit to anything longer.